Lee, H.; Haque, S.; Gupta, R.; Kolitz, J.E.; Allen, S.L.; Rai, K.; Chiorazzi, N.; Mongini, P.K.A.
BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism. Lymphatics 2024, 2, 50-78.
https://doi.org/10.3390/lymphatics2020005
AMA Style
Lee H, Haque S, Gupta R, Kolitz JE, Allen SL, Rai K, Chiorazzi N, Mongini PKA.
BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism. Lymphatics. 2024; 2(2):50-78.
https://doi.org/10.3390/lymphatics2020005
Chicago/Turabian Style
Lee, Hyunjoo, Shabirul Haque, Rashmi Gupta, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Nicholas Chiorazzi, and Patricia K. A. Mongini.
2024. "BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism" Lymphatics 2, no. 2: 50-78.
https://doi.org/10.3390/lymphatics2020005
APA Style
Lee, H., Haque, S., Gupta, R., Kolitz, J. E., Allen, S. L., Rai, K., Chiorazzi, N., & Mongini, P. K. A.
(2024). BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism. Lymphatics, 2(2), 50-78.
https://doi.org/10.3390/lymphatics2020005